Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:522 (8 March), doi:10.1136/bmj.39507.412373.80
| The first 150 words of the full text of this article appear below. |
When organising an international medical conference in Sydney, we righteously spurned sponsorship from "big pharma."1 Caesars wife had nothing on us. We solicited support elsewhere and ran a successful conference.
But, when the final figures were reckoned, we made a sobering discovery. Our success was due in large measure to big pharma and "big surgical instrument maker." They had paid the registration fees of large contingents from two Asian countries.
Our enthusiasm at seeing those delegates at the registration desk on day 1 was totally negated when, having taken photographs in front of the conference banners, they vanished—to tour the city and, for all we know, the neighbouring countryside or the rest of Australia.
How common is this behaviour? What do these companies expect, and receive, in exchange? Is this sponsored tourism acceptable in their home countries? Are the same sorts of offerings made to Australian doctors regarding trips overseas?
Peter C Arnold, retired general practitioner
1 Edgecliff, NSW 2027, Australia
parnold@ozemail.com.au
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?